Related Experiment Videos
Cytofluorimetric analysis of CD34 cells
Bone Marrow Transplantation
|February 16, 1999
Summary
Accurate enumeration of CD34-positive cells, crucial for hematopoietic stem cell measurement, requires standardized whole blood analysis. Optimizing lysis and antibody selection minimizes lab variations for reliable results.
Area of Science:
- Hematology
- Immunophenotyping
- Flow Cytometry
Background:
- Cytofluorimetric enumeration of CD34-positive cells is vital for assessing hematopoietic stem cells.
- Significant inter-laboratory variations in multicenter quality control studies highlight technical challenges.
- Standardization is needed to improve the reliability of CD34 cell counts.
Purpose of the Study:
- To identify technical factors influencing the accuracy of CD34-positive cell enumeration.
- To provide recommendations for optimizing the methodology for CD34 analysis.
- To explore the utility of multiparametric flow cytometry in specific clinical scenarios.
Main Methods:
- Analysis of CD34-positive cells performed on whole blood samples.
- Evaluation of different lysis reagents, with NH4Cl or NH4Cl-derived reagents showing optimal results.
- Recommendation for using a class III, preferably PE-conjugated, monoclonal antibody for CD34 detection.
- Comparison of various analysis protocols (Milan, ISHAGE, Dutch, commercial kit) on fresh samples.
Main Results:
- No significant differences in absolute CD34 counts were observed between different protocols when using fresh, viable samples.
- Whole blood analysis with appropriate lysis and antibody selection is crucial.
- Multiparametric (3-4 color) analysis may be necessary for complex cases like scoring apheresis products in ALL.
Conclusions:
- Standardized protocols for whole blood lysis and antibody selection are essential to reduce variability in CD34 enumeration.
- Multiparametric flow cytometry aids in evaluating apheresis products and optimizing leukapheresis timing.
- Accurate CD34 counts are critical for effective hematopoietic stem cell transplantation and monitoring.